For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
News Release
#Neverneeded Regulation Report: CDC, FDA Response to COVID-19 Hindered by Mission Creep
The nation’s top federal agencies tasked with protecting public health have been increasingly distracted over recent years by dubious priorities having nothing to do with…
Study
Narrow the Focus of the Centers for Disease Control and Prevention and Food and Drug Administration
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) may well have taken their eye off the ball by…
Youtube
VIDEO: Iain Murray Discusses #NeverNeeded Regulations and COVID-19
Vice President for Strategy and Senior Fellow Iain Murray joins Dana Loesch to discuss #neverneeded regulations and COVID-19…
The Epoch Times
Federal, State, and Local Governments Shed Over 170 Regulations to Fight Pandemic
The Epoch Times cites CEI on #neverneeded regulations: Even more regulations can be scrapped to empower American industry to help with the crisis,…
Bloomberg Law
Covid-19 Revives Debate over Economic Benefits of Deregulation
Bloomber Law cites Vice President for Strategy and Senior Fellow Iain Murray on #neverneeded regulations: Direct government aid won’t be enough to get…
CATO
Regulation after COVID-19
The CATO Institute cites CEI on #neverneeded regulations: Many of these regulations have no sound public justification whether in or outside of an…